You can access the annual and quarterly cash flow statements of Mainz Biomed N V Ord Shs to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---2.71M
Net income from continuing operations
---5.08M
Operating gains losses
--58.00K
Other non-cash items
--178.43K
Change in working capital
--739.25K
-Change in receivables
--65.90K
-Change in inventory
--148.06K
-Change in prepaid expenses
--84.29K
-Change in payables and accrued expense
--528.73K
Cash from non-recurring investing activities
Cash from operating activities
---2.71M
Investing cash flow
Net cash from continuing investing activities
--650.66K
Capital expenditures
--650.66K
Net cash flow from disposal of fixed assets
--658.00
Net cash flow from intangible asset transactions
--650.00K
Cash from non-current investing activities
Net cash flow from investing activities
---650.66K
Financing cash flow
Net cash flow from debt Issuance/repayment
---84.06K
Net cash flow from other financing activities
---736.95K
Net cash from non-recurrent financing activities
Net cash flow
Beginning cash balance
--889.09K
Current period cash flow changes
--3.86M
Effect of exchange rate changes
---44.70K
Ending cash balance
--4.75M
Free cash flow
---3.36M
Currency unit
USD
Audit opinions
--
FAQs
What is the cash flow statement?
This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.